Skip to main content
main-content

28.04.2016 | Biomarkers (S Dawood, Section Editor) | Ausgabe 2/2016

Current Breast Cancer Reports 2/2016

Emerging Biomarkers of the Future: Changing Clinical Practice for 2020

Zeitschrift:
Current Breast Cancer Reports > Ausgabe 2/2016
Autoren:
Hazem I. Assi, Rita E. Assi, Nagi S. El Saghir
Wichtige Hinweise
This article is part of the Topical Collection on Biomarkers

Abstract

Progress in biomarker development has greatly enhanced our ability to categorize breast cancer into several clinical subtypes and to deliver better personalized therapies. Technological advances in gene expression profiling, signaling pathways, proliferation markers and tumor monitoring through detection of circulating tumor cells and free DNA, and measurements of genomic instability and germline mutations are being vigorously pursued in breast cancer research. Their application in routine clinical practice is increasing and helping further development of precision medicine. Ongoing challenges include assessing the utility and feasibility of these tests, interpreting the large amounts of genomic data that are being generated, translating the information to clinical practice, and constructing clinical trials on molecularly driven approaches. In this article, we will review current and emerging promising biomarkers and their roles in the management of patients with breast cancer.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

★ PREMIUM-INHALT
e.Med Interdisziplinär

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Premium-Inhalten der Fachzeitschriften, inklusive eines Print-Abos.

Jetzt abonnieren und bis 25. Juni einen 50 € Amazon-Gutschein sichern.

Weitere Produktempfehlungen anzeigen
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 2/2016

Current Breast Cancer Reports 2/2016Zur Ausgabe

Local-Regional Evaluation and Therapy (EP Mamounas, Section Editor)

Nipple-Sparing Mastectomy in Patients with Germline BRCA Mutations: Is it Safe?

Local-Regional Evaluation and Therapy (EP Mamounas, Section Editor)

The Optimal Approach to Post-Mastectomy and Post-Lumpectomy Breast Reconstruction

Local-Regional Evaluation and Therapy (EP Mamounas, Section Editor)

Margins in Breast-Conserving Surgery for Early Breast Cancer: How Much is Good Enough?

Local-Regional Evaluation and Therapy (EP Mamounas, Section Editor)

Regional Nodal Radiotherapy in Early-Stage Breast Cancer: Where Are We in 2016?

  1. Das kostenlose Testabonnement läuft nach 14 Tagen automatisch und formlos aus. Dieses Abonnement kann nur einmal getestet werden.

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise